Clinical Trials

NCT04659993 | TERMINATED | NA

10 participants

Cancer Within a Pandemic: A Telemental Health Intervention

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-03-10

Completion:

2021-06-09

Conditions

• Cancer
• Survivorship
• Depression, Anxiety

Interventions

• BEHAVIORAL

Results Available

NCT04636229 | COMPLETED | PHASE3

516 participants

Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2020-12-14

Completion:

2023-07-30

Conditions

• Knee Osteoarthritis

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT04632927 | COMPLETED | PHASE3

119 participants

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2020-12-21

Completion:

2024-10-22

Conditions

• Psoriatic Arthritis

Interventions

• BIOLOGICAL

Results Available

NCT04623216 | TERMINATED | PHASE1/PHASE2

24 participants

Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-09-14

Completion:

2024-08-22

Conditions

• Acute Myeloid Leukemia

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT04610346 | COMPLETED | NA

17 participants

Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2023-03-30

Completion:

2024-08-28

Conditions

• Aphasia

Interventions

• BEHAVIORAL

Results Available

NCT04601831 | COMPLETED | PHASE1/PHASE2

14 participants

'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2020-12-23

Completion:

2024-08-06

Conditions

• Non-Hodgkin Lymphoma

Interventions

• RADIATION

No Results Yet

NCT04541589 | COMPLETED | PHASE2

206 participants

Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-01-05

Completion:

2024-08-19

Conditions

• Sjogren's Syndrome

Interventions

• DRUG
• OTHER

Results Available

NCT04541017 | TERMINATED | PHASE1/PHASE2

8 participants

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-04-06

Completion:

2024-10-24

Conditions

• Mycosis Fungoides
• Recurrent Mycosis Fungoides
• Recurrent Mycosis Fungoides and Sezary Syndrome
• Recurrent Sezary Syndrome
• Refractory Mycosis Fungoides
• Refractory Mycosis Fungoides and Sezary Syndrome
• Refractory Sezary Syndrome
• Sezary Syndrome
• Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
• Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
• Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
• Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8

Interventions

• PROCEDURE
• BIOLOGICAL

Results Available

NCT04533555 | COMPLETED | NA

749 participants

Genetic Testing in Young Adults With Cancer Study

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2020-12-01

Completion:

2025-09-26

Conditions

• Cancer

Interventions

• GENETIC

No Results Yet

NCT04526639 | COMPLETED | NA

14 participants

VR Cognitive Rehabiliation for Pediatric TBI

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-09-03

Completion:

2024-08-31

Conditions

• TBI (Traumatic Brain Injury)

Interventions

• BEHAVIORAL

Results Available

NCT04495751 | COMPLETED | EARLY_PHASE1

64 participants

Muscadine Grape Extract to Improve Fatigue

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-04-20

Completion:

2024-08-26

Conditions

• Fatigue

Interventions

• DIETARY_SUPPLEMENT
• DRUG
• OTHER

Results Available

NCT04390763 | TERMINATED | PHASE2

164 participants

Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2020-10-16

Completion:

2024-04-26

Conditions

• Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT04376346 | COMPLETED | NA

439 participants

Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-08-04

Completion:

2024-02-25

Conditions

• Alcohol Exposed Pregnancy

Interventions

• BEHAVIORAL

Results Available

NCT04337554 | COMPLETED

47 participants

Exoskeleton Footwear to Improve Walking

Study Type:

OBSERVATIONAL

Last Updated:

2025-10-16

Start Date:

2020-08-01

Completion:

2025-09-30

Conditions

• Peripheral Arterial Disease

Interventions

• DEVICE

No Results Yet

NCT04278417 | COMPLETED | PHASE3

689 participants

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2020-11-19

Completion:

2023-10-30

Conditions

• Proliferative Diabetic Retinopathy

Interventions

• BIOLOGICAL
• PROCEDURE

Results Available

NCT04272034 | TERMINATED | PHASE1

105 participants

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2021-03-26

Completion:

2024-08-16

Conditions

• Advanced Solid Tumors
• MSI-H/dMMR Tumors
• Cutaneous Squamous Cell Carcinoma
• Urothelial Carcinoma, HCC
• Cervical Cancer
• Esophageal Squamous Cell Carcinoma
• Merkel Cell Carcinoma
• Small-cell Lung Cancer
• Mesothelioma
• PD-L1 Amplified Tumor (9p24.1)
• Nasopharyngeal Carcinoma
• Cyclin-dependent Kinase 12 Mutated Tumors
• Basal Cell Carcinoma (Unresectable or Metastatic)
• Sarcomatoid Renal Cell Carcinoma
• Clear Cell Ovarian or Endometrial Carcinoma
• Anal Carcinoma
• Squamous Cell Penile Carcinoma
• DNA Polymerase Epsilon Mutated Tumors (P286R and V411L)

Interventions

• DRUG

No Results Yet

NCT04178122 | COMPLETED | NA

112 participants

Million Veteran Program Return of Actionable Results

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2020-02-27

Completion:

2024-09-08

Conditions

• Cardiovascular Disease

Interventions

• GENETIC

Results Available

NCT04141761 | ACTIVE_NOT_RECRUITING | PHASE2

43 participants

Probiotics in Newly Diagnosed T1D

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-04-01

Completion:

2023-03-30

Conditions

• Type 1 Diabetes
• Type1diabetes
• Type 1 Diabetes Mellitus

Interventions

• DIETARY_SUPPLEMENT
• OTHER

No Results Yet

NCT04123496 | COMPLETED | NA

38 participants

rTMS to Enhance Cognitive Performance and Promote Resilience

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-11-21

Completion:

2021-09-27

Conditions

• Cognition
• Stress Reaction

Interventions

• DEVICE

Results Available

NCT04066244 | TERMINATED | PHASE2

28 participants

Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-12-30

Completion:

2024-02-01

Conditions

• Amyotrophic Lateral Sclerosis

Interventions

• DRUG

Results Available

NCT04053868 | COMPLETED | NA

17 participants

Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-12-09

Completion:

2022-03-31

Conditions

• Nicotine Administration & Dosage
• E-cigarettes
• Vaping
• E-Liquid
• Tobacco Smoking

Interventions

• OTHER

Results Available

NCT04050462 | TERMINATED | PHASE2

13 participants

Nivolumab Combined With BMS-986253 in HCC Patients

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-09-12

Completion:

2025-01-31

Conditions

• Hepatocellular Carcinoma

Interventions

• DRUG

Results Available

NCT04042467 | COMPLETED | NA

900 participants

Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-11-06

Completion:

2024-01-17

Conditions

• Behavior, Health
• Child Obesity

Interventions

• BEHAVIORAL

Results Available

NCT04015518 | COMPLETED | PHASE2

152 participants

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-07-31

Completion:

2020-08-06

Conditions

• Palmoplantar Pustulosis (PPP)

Interventions

• DRUG

Results Available

NCT04010240 | COMPLETED

3820 participants

A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study

Study Type:

OBSERVATIONAL

Last Updated:

2025-10-16

Start Date:

2015-12-23

Completion:

2022-12-31

Conditions

• Metastatic Solid Tumors

Interventions

• OTHER

Results Available

NCT03879161 | WITHDRAWN | NA

0 participants

A Percutaneous Ultrasound Device With Needle Guide for Vascular Access

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2026-09-30

Completion:

2028-12-31

Conditions

• Vascular Access

Interventions

• DEVICE

No Results Yet

NCT03867201 | COMPLETED | PHASE3

557 participants

Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-08-26

Completion:

2021-08-11

Conditions

• Migraine

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT03827291 | COMPLETED | PHASE4

35 participants

QL Block With Exparel in Colectomy

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-10-31

Completion:

2022-12-02

Conditions

• Laparotomy
• Colectomy

Interventions

• DRUG
• OTHER

Results Available

NCT03822468 | COMPLETED | PHASE2

376 participants

Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-06-11

Completion:

2021-06-11

Conditions

• Breast Cancer

Interventions

• DRUG

Results Available

NCT03792841 | TERMINATED | PHASE1

212 participants

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-02-05

Completion:

2023-06-29

Conditions

• Metastatic Castration-resistant Prostate Cancer
• Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT03782792 | COMPLETED | PHASE2

53 participants

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-01-31

Completion:

2020-09-23

Conditions

• Generalized Pustular Psoriasis

Interventions

• DRUG

Results Available

NCT03769168 | COMPLETED | PHASE3

55 participants

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-06-07

Completion:

2024-11-07

Conditions

• Juvenile Psoriatic Arthritis
• Enthesitis Related Arthritis

Interventions

• DRUG

Results Available

NCT03760744 | COMPLETED | NA

18 participants

Imaging Biomarkers of Lymphatic Dysfunction

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-01-23

Completion:

2025-03-15

Conditions

• Secondary Lymphedema

Interventions

• PROCEDURE

Results Available

NCT03752970 | COMPLETED | PHASE2

27 participants

A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-02-05

Completion:

2021-12-01

Conditions

• Crohn Disease

Interventions

• DRUG

Results Available

NCT03584854 | COMPLETED | PHASE4

100 participants

Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-03-01

Completion:

2022-05-22

Conditions

• Postpartum Hemorrhage
• Uterine Atony

Interventions

• DRUG

Results Available

NCT03581123 | COMPLETED | PHASE3

1000 participants

Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2018-11-01

Completion:

2024-06-12

Conditions

• Acute Pain
• Low Back Pain, Mechanical

Interventions

• BEHAVIORAL
• OTHER
• COMBINATION_PRODUCT
• DRUG

Results Available

NCT03507608 | COMPLETED | EARLY_PHASE1

25 participants

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2019-05-10

Completion:

2024-09-30

Conditions

• Prostate Cancer

Interventions

• DRUG
• OTHER

Results Available

NCT03482635 | COMPLETED | PHASE2/PHASE3

98 participants

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2018-03-27

Completion:

2020-05-18

Conditions

• Colitis, Ulcerative

Interventions

• DRUG

Results Available

NCT03474965 | COMPLETED | PHASE2

117 participants

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2018-10-01

Completion:

2024-11-06

Conditions

• Sickle Cell Disease (SCD)

Interventions

• DRUG

Results Available

NCT03296813 | COMPLETED | PHASE3

2973 participants

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

Study Type:

INTERVENTIONAL

Last Updated:

2025-10-16

Start Date:

2018-07-11

Completion:

2022-07-29

Conditions

• Heart Failure

Interventions

• DRUG

Results Available